IMMUNE-MEDIATED MYOSITIS

This adverse event was reported 2759 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED MYOSITIS:

# Drug Count
0 ATORVASTATIN CALCIUM 353
1 ATORVASTATIN CALCIUM, FILM COATED 342
2 NIVOLUMAB 248
3 METFORMIN 237
4 METFORMIN ER 500 MG 237
5 METFORMIN ER 750 MG 237
6 SIMVASTATIN 183
7 METHOTREXATE SODIUM 166
8 ASPIRIN 162
9 ASPIRIN 325 MG 161
See all common drugs associated with IMMUNE-MEDIATED MYOSITIS

IMMUNE-MEDIATED MYOSITIS is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 ENSITRELVIR 1 0.0556
1 ATORVALIQ 1 0.0476
2 DELANDISTROGENE MOXEPARVOVEC-ROKL 16 0.0435
3 ANTACID TABLETS 1 0.0303
4 TELMISARTAN AND AMLODIPINE 3 0.0300
5 AMLODIPINE BESYLATE VALSARTAN HYDROCHLOROTHIAZIDE 1 0.0244
6 ADENINE 1 0.0204
7 NIVOLUMAB AND RELATLIMAB-RMBW 9 0.0175
8 VARDENAFIL 8 0.0134
9 PENPULIMAB 1 0.0102
See all drugs enriched for association with IMMUNE-MEDIATED MYOSITIS